Hepatitis C virus (HCV) screening and treatment in South Texas US-Mexico border persistent poverty counties

被引：0
|
作者：
Flores, Bertha E.
Guerrero, Juan
Bobadilla, Raudel
Craven, Catherine K.
机构：
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2023年 / 32卷 / 12期
关键词：
D O I：
10.1158/1538-7755.DISP23-IA045
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA045
引用
收藏
页数：1
相关论文
共 27 条
  • [21] Treatment of chronic hepatitis C virus (HCV) infections with Direct Acting Antivirals in the New Mexico State Prison System using the Project ECHO Model
    Thornton, K.
    Deming, P.
    Sedillo, M.
    Arora, S.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S492 - S492
  • [22] Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural US communities
    Estadt, Angela T.
    Kline, David
    Miller, William C.
    Feinberg, Judith
    Hurt, Christopher B.
    Mixson, L. Sarah
    Friedmann, Peter D.
    Lowe, Kelsa
    Tsui, Judith I.
    Young, April M.
    Cooper, Hannah
    Korthuis, P. Todd
    Pho, Mai T.
    Jenkins, Wiley
    Westergaard, Ryan P.
    Go, Vivian F.
    Brook, Daniel
    Smith, Gordon
    Rice, Dylan R.
    Lancaster, Kathryn E.
    HARM REDUCTION JOURNAL, 2024, 21 (01)
  • [23] Differences in Hepatitis C Virus (HCV) Testing and Treatment by Opioid, Stimulant, and Polysubstance Injection Among People who Inject Drugs (PWID) in Rural US Communities
    Estadt, Angela
    Miller, William C.
    Kline, David
    Tsui, Judith I.
    Young, April M.
    Cooper, Hannah
    Korthuis, P. Todd
    Feinberg, Judith
    Smith, Gordon
    Pho, Mai T.
    Jenkins, Wiley
    Friedmann, Peter D.
    Westergaard, Ryan P.
    Go, Vivian F.
    Mixson, L. Sarah
    Brook, Daniel
    Lowe, Kelsa
    Hurt, Christopher B.
    Rice, Dylan
    Lancaster, Kathryn E.
    DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [24] Primary Care Physician Perspectives on Hepatitis C Virus (HCV) Screening, Diagnosis, Referral and Treatment in the Era of Highly Effective Oral Anti-Viral Therapy
    Thomson, Mary
    Konerman, Monica
    Lok, Anna S.
    HEPATOLOGY, 2015, 62 : 495A - 496A
  • [25] The Impact of Birth-Cohort Screening for Hepatitis C Virus (HCV) Compared With Current Risk-Based Screening on Lifetime Incidence of and Mortality From Advanced Liver Disease (AdvLD) in the United States (US)
    McGarry, Lisa
    Davis, Gary L.
    Younossi, Zobair M.
    Pawar, Vivek
    Rubin, Jaime
    Parekh, Hemangi
    Weinstein, Milton
    GASTROENTEROLOGY, 2011, 140 (05) : S890 - S890
  • [26] Treatment of US Veterans with hepatitis C virus (HCV) genotype (GT) 1 infection: effectiveness of Ledipasvir/Sofosbuvir (Harvoni®) and Ombitasvir/Paritavir/Ritonavir/Dasubuvir (Viekira Pak®) regimens
    Issa, Danny
    Forte, Veda
    Tassone, Daniel
    Gilles, HoChong
    Solomon, Cynthia L.
    Owens, Stacy
    Obolewicz, Barbara
    Neuman, Douglas M.
    Fuchs, Michael
    HEPATOLOGY, 2016, 64 : 991A - 992A
  • [27] Impact of early screening and treatment of hepatitis C virus and improvements in risk reduction on HCV transmission among HIV-infected men who have sex with men in France: A modeling approach
    Castry, Mathieu
    Cousien, Anthony
    Supervie, Virginie
    Velter, Annie
    Ghosn, Jade
    Paltiel, A. David
    Yazdanpanah, Yazdan
    Deuffic-Burban, Sylvie
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E327 - E327
123